The purchase includes Deciphera’s oral drug Qinlock to treat a type of gastrointestinal cancer, which received the U.S. Food and Drug Administration’s full approval in 2020.
News
Japan’s Ono Pharma says $2.4 bln Deciphera purchase ‘first step’ for global expansion
May 14, 2024
The purchase includes Deciphera’s oral drug Qinlock to treat a type of gastrointestinal cancer, which received the U.S. Food and Drug Administration’s full approval in 2020.